DNA methylation of the 5′‐UTR DAT 1 gene in Parkinson's disease patients
Acta Neurologica Scandinavica2020Vol. 142(3), pp. 275–280
Citations Over TimeTop 21% of 2020 papers
Alfonso Rubino, Claudio D’Addario, Martina Di Bartolomeo, Enrico Michele Salamone, Nicoletta Locuratolo, Francesco Fattapposta, Nicola Vanacore, Esterina Pascale
Abstract
Our results do seem to suggest that the methylation level of CpG5 is different between PD patients and controls. Moreover, this methylation level for CpG5 may be associated also with the stage of disease.
Related Papers
- → Changes of DNA methylation of Isoetes sinensis under Pb and Cd stress(2018)15 cited
- → Silencing of Syntaxin 1A in the Dopaminergic Neurons Decreases the Activity of the Dopamine Transporter and Prevents Amphetamine-Induced Behaviors in C. elegans(2018)9 cited
- → Recovery of dopaminergic system after cocaine exposure and impact of a long‐acting cocaine hydrolase(2022)9 cited
- → Methylation of CpG sites in BCL2 major breakpoint region and the increase of BCL2/JH translocation with aging(2015)
- → Dopaminergic performances in patients with parkinsonism — A combination study of dopamine transporter SPECT, dopamine synthesis and receptor pet(2017)